MCID: FLL021
MIFTS: 11

Follicular Basal Cell Carcinoma

Categories: Cancer diseases

Aliases & Classifications for Follicular Basal Cell Carcinoma

MalaCards integrated aliases for Follicular Basal Cell Carcinoma:

Name: Follicular Basal Cell Carcinoma 12
Follicular Basal Cell Carcinoma 12
Basal Cell Carcinoma - Follicular 69

Classifications:



External Ids:

Disease Ontology 12 DOID:4295

Summaries for Follicular Basal Cell Carcinoma

MalaCards based summary : Follicular Basal Cell Carcinoma, is also known as follicular basal cell carcinoma. The drugs Fentanyl and Pancreatic Polypeptide have been mentioned in the context of this disorder. Affiliated tissues include lung, liver and brain.

Related Diseases for Follicular Basal Cell Carcinoma

Symptoms & Phenotypes for Follicular Basal Cell Carcinoma

Drugs & Therapeutics for Follicular Basal Cell Carcinoma

Drugs for Follicular Basal Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 42)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
3 Liver Extracts Phase 3,Phase 2,Phase 1
4 Analgesics Phase 3
5 Central Nervous System Depressants Phase 3
6 Adjuvants, Anesthesia Phase 3
7 Narcotics Phase 3
8 Analgesics, Opioid Phase 3
9 Anesthetics Phase 3
10 Anesthetics, General Phase 3
11 Anesthetics, Intravenous Phase 3
12 Peripheral Nervous System Agents Phase 3
13 Cola Nutraceutical Phase 3,Phase 2,Phase 1
14
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
15
Indinavir Approved Phase 2 150378-17-9 5362440
16
Aldesleukin Approved Phase 2 85898-30-2, 110942-02-4
17
protease inhibitors Phase 2
18 Cytochrome P-450 CYP3A Inhibitors Phase 2
19 HIV Protease Inhibitors Phase 2
20 Cytochrome P-450 Enzyme Inhibitors Phase 2
21 Anti-HIV Agents Phase 2
22 Anti-Infective Agents Phase 2,Phase 1
23 Anti-Retroviral Agents Phase 2
24 Antiviral Agents Phase 2
25 Vaccines Phase 2
26
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
27
Docetaxel Approved May 1996, Investigational Phase 1 114977-28-5 148124 9877265
28
Entinostat Investigational Phase 1 209783-80-2
29 Histone Deacetylase Inhibitors Phase 1
30 Angiogenesis Inhibitors Phase 1
31 Angiogenesis Modulating Agents Phase 1
32 Anti-Bacterial Agents Phase 1
33 Immunosuppressive Agents Phase 1
34 Antimitotic Agents Phase 1
35
Nicotine Approved 54-11-5 942 89594
36
Gefitinib Approved, Investigational 184475-35-2 123631
37 Central Nervous System Stimulants
38 Cholinergic Agents
39 Neurotransmitter Agents
40 Nicotinic Agonists
41 Protein Kinase Inhibitors
42 Autonomic Agents

Interventional clinical trials:

(show all 13)

id Name Status NCT ID Phase Drugs
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
2 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
3 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Completed NCT00019331 Phase 2 DetoxPC
4 A Study in Advanced Cancer Completed NCT01226485 Phase 1 RXDX-109
5 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer Completed NCT00045006 Phase 1 vorinostat
6 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat
7 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
8 GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors Completed NCT00607724 Phase 1 GDC-0449
9 NGR-TNF in Treating Patients With Advanced Solid Tumors Completed NCT00098943 Phase 1
10 Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer Active, not recruiting NCT00470496 Phase 1 HPPH;photodynamic therapy
11 S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors Withdrawn NCT00937417 Phase 1 docetaxel;vandetanib
12 Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer Completed NCT00068497 gefitinib
13 Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Completed NCT00002520 nicotine

Search NIH Clinical Center for Follicular Basal Cell Carcinoma

Genetic Tests for Follicular Basal Cell Carcinoma

Anatomical Context for Follicular Basal Cell Carcinoma

MalaCards organs/tissues related to Follicular Basal Cell Carcinoma:

39
Lung, Liver, Brain

Publications for Follicular Basal Cell Carcinoma

Variations for Follicular Basal Cell Carcinoma

Expression for Follicular Basal Cell Carcinoma

Search GEO for disease gene expression data for Follicular Basal Cell Carcinoma.

Pathways for Follicular Basal Cell Carcinoma

GO Terms for Follicular Basal Cell Carcinoma

Sources for Follicular Basal Cell Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....